Home/ Stocks/ TYRA

Tyra Biosciences, Inc. Common Stock

TYRA XNAS

$26.51 -1.16 (-4.30%) ▼ 15-min delayed

Open

$27.38

High

$27.82

Low

$26.14

Volume

820.6K

Market Cap

$1.61B

About Tyra Biosciences, Inc. Common Stock

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 87 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q2 2026	$0	$-45,558,000	$-0.69
Q1 2026	$0	$-39,305,000	$-0.64
FY 2025	$0	$-119,947,000	$-2.01
Q3 2025	$0	$-29,868,000	$-0.50

Earnings & Analyst Ratings

Next Earnings: Tue, Nov 3, 2026

Calendar →

Related Market News

No specific coverage for TYRA yet. Check out our latest market news or earnings calendar.

Get TYRA Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Tyra Biosciences, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.